Maria Lia Palomba

40PUBLICATIONS
220CO-AUTHORS
Predictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Aug 31, 2026
Tumor CD19 Expression Determines Distinct Clinical Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.

|Jan 28, 2026
Phase I Study of Mogamulizumab in Combination with Pembrolizumab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma-A National Cancer Institute Experimental Therapeutics Clinical Trials Network (NCI-ETCTN) Trial.

Erel Joffe, Anita Kumar, Joseph M Tuscano

|Aug 26, 2025
Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma.

Michael Winkelmann, Sandeep S Raj, Michael D Jain

|Jul 02, 2025
Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies.

Sigrun Einarsdottir, Stephanie Lobaugh, Danny Luan

|Apr 15, 2025
Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysis.

Y Sawalha, S Sarosiek, R L Welkie

|Apr 14, 2025
CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma.

Alejandro Luna, Sean M Devlin, Kai Rejeski

Pageof 7

Frequent Collaborators

19 joint publications

Gilles Salles

14 joint publications

Miguel-Angel Perales

12 joint publications

Jae Park

11 joint publications

Richard Lin